Patents by Inventor Arjun RAGHUWANSHI

Arjun RAGHUWANSHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPTHALMIC COMPOSITION OF BEVACIZUMAB
    Publication number: 20220265825
    Abstract: The present invention pertains to an ophthalmic composition of Bevacizumab, in a single use prefilled syringe which is safe, non-toxic and efficacious for administration during the shelf life, characterised in that the ophthalmic solution is controlled with respect to the number of sub-visible particulate matter with significantly reduced endotoxin levels and with low aggregate level that are suitable for intravitreal use during the shelf life of 2 years of the product.
    Type: Application
    Filed: July 31, 2020
    Publication date: August 25, 2022
    Applicant: GENNOVA BIOPHARMACEUTICALS LIMITED
    Inventors: Kushal GARIMA, Swarnendu KAVIRAJ, Arjun RAGHUWANSHI, Sanjay SINGH
  • Purification process for isolation and commercial production of recombinant TNK-tPA tenecteplase
    Patent number: 10544408
    Abstract: The present invention relates to a novel process of isolating and purifying tissue plasminogen activator and its variants more specifically TNK-tPA from CHO cells and describes an industrially applicable, simple, cost effective, robust and highly efficient process of TNK-tPA purification.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: January 28, 2020
    Assignee: GENNOVA BIOPHARMACEUTICALS LIMITED
    Inventors: Arjun Raghuwanshi, Shrawan Singh Kumar, Ankit Kumar, Mihir Sahoo Ranjan, Sanjay Singh
  • Process for purification of rHu-GCSF
    Patent number: 10519209
    Abstract: The present invention provides a novel, scalable and industrially viable downstream process for purification of recombinant human G-CSF.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: December 31, 2019
    Assignee: GENNOVA BIOPHARMACEUTICALS LIMITED
    Inventors: Arjun Raghuwanshi, Shrawan Kumar Singh, Nidhiben Thaker, Shagun Shankar, Pavan Kardile, Sanjay Singh
  • A NOVEL PURIFICATION PROCESS FOR ISOLATION AND COMMERCIAL PRODUCTION OF RECOMBINANT TNK-TPA TENECTEPLASE
    Publication number: 20180223270
    Abstract: The present invention relates to a novel process of isolating and purifying tissue plasminogen activator and its variants more specifically TNK-tPA from CHO cells and describes an industrially applicable, simple, cost effective, robust and highly efficient process of TNK-tPA purification.
    Type: Application
    Filed: October 19, 2015
    Publication date: August 9, 2018
    Applicant: GENNOVA BIOPHARMACEUTICALS LIMITED
    Inventors: Arjun RAGHUWANSHI, Shrawan SINGH KUMAR, Ankit KUMAR, Mihir SAHOO RANJAN, Sanjay SINGH
  • A NOVEL PROCESS FOR PURIFICATION OF RHU-GCSF
    Publication number: 20170210784
    Abstract: The present invention provides a novel, scalable and industrially viable downstream process for purification of recombinant human G-CSF.
    Type: Application
    Filed: July 13, 2015
    Publication date: July 27, 2017
    Inventors: Arjun RAGHUWANSHI, Shrawan Kumar SINGH, Nidhiben THAKER, Shagun SHANKAR, Pavan KARDILE, Sanjay SINGH